Home > Healthcare > Medical Devices > Diagnostic Devices > Intrapartum Monitoring Devices Market
Intrapartum Monitoring Devices Market size is anticipated to witness substantial gains from 2024 to 2032 driven by the surging popularity of safer and innovative ways of fetal evaluation during labor. In September 2023, the National Institutes of Health launched a $2 million prize competition to accelerate the development of diagnostic and monitoring technologies that aimed to improve fetal health outcomes in low-resource settings.
Additionally, technological advancements, including the integration of wireless connectivity and real-time data analytics, have enhanced the accuracy and efficiency of monitoring devices, contributing to their widespread adoption.
Recent advancements in the non-invasive monitoring technologies and the introduction of electronic fetal monitoring will boost the industry growth. Preterm births, infections, birth defects, and intrapartum complications, such as birth asphyxia are among the leading causes of many neonatal deaths. According to National Institutes of Health, birth asphyxia accounts for 900,000 deaths every year. The increasing focus on preventing infant mortality in the early stages of birth will proliferate the demand for intrapartum procedures.
Based on product, electrode segment is anticipated to depict significant development through 2032 owing to the growing use of internal fetal heart rate monitoring devices. It has been estimated that approximately 22% of all deliveries make use of fetal scalp electrodes (FSE) to monitor fetal health. The increasing incidences of neonatal morbidity across developed and developing countries are also expected to propel product adoption in the upcoming period.
Hospitals segment is expected to record substantial market share by 2032, as they offer a comprehensive and technologically advanced environment. With a focus on ensuring the well-being of both mothers and infants, hospitals provide a setting where skilled healthcare professionals readily integrate and interpret real-time data using intrapartum monitoring devices. The centralized nature also ensures that emergency interventions can be promptly administered when necessary, contributing to improved maternal and fetal outcomes.
The intrapartum monitoring devices market size in North America is poised to experience a decent growth between 2024 and 2032, as multiple entities in the region are empowering the space of fetal monitoring software and devices. For instance, the American College of Obstetricians & Gynecologists recommends the use of intermittent fetal monitoring deployed with electronic monitors and other tools. Moreover, the presence of some of the leading manufacturers and the rapid stream of innovations and developments will contribute to the industry expansion in the region.
Some major companies in the intrapartum monitoring devices industry include :
These players are foraying into new collaborations, partnerships, and joint ventures to expand their business footprint globally and boost product innovation.